{"id":650,"date":"2022-03-18T11:43:28","date_gmt":"2022-03-18T11:43:28","guid":{"rendered":"https:\/\/huphar.org\/huphar60\/?p=650"},"modified":"2022-05-27T15:02:06","modified_gmt":"2022-05-27T15:02:06","slug":"program-2","status":"publish","type":"post","link":"https:\/\/huphar.org\/huphar60\/program-2\/","title":{"rendered":"Program"},"content":{"rendered":"

A konferencia\u00a0 programja<\/strong><\/span><\/p>\n

 <\/p>\n

    \n
  1. j\u00fanius 7. (kedd)<\/strong><\/li>\n<\/ol>\n

    11:00\u00a0\u00a0 Regisztr\u00e1ci\u00f3<\/strong><\/p>\n

    12:00\u00a0\u00a0 Eb\u00e9d-AVAR Hotel **** superior \u00c9tterem<\/strong><\/p>\n

    13:00-13:45\u00a0\u00a0\u00a0\u00a0 Konferencia megnyit\u00e1sa-T\u00f6lgyes terem<\/strong><\/p>\n

    13:00 \u00a0Monostory Katalin: K\u00f6sz\u00f6nt\u0151<\/strong><\/p>\n

    13:05 \u00a0Vizi E. Szilveszter: <\/strong>A Magyar K\u00eds\u00e9rletes \u00e9s Klinikai Farmakol\u00f3giai T\u00e1rsas\u00e1g hozz\u00e1j\u00e1rul\u00e1sa a magyar tudom\u00e1ny fejl\u0151d\u00e9s\u00e9hez az elm\u00falt 60 \u00e9vben<\/p>\n

    13:25\u00a0 Ferdinandy P\u00e9ter<\/strong>: Az MFT strat\u00e9giai szerepe a j\u00f6v\u0151ben a hazai preklinikai- \u00e9s klinikai gy\u00f3gyszerkutat\u00e1sban \u00e9s fejleszt\u00e9sben valamint ezek oktat\u00e1s\u00e1ban<\/p>\n

    13:45\u00a0\u00a0 Kotschy Andr\u00e1s<\/strong><\/p>\n

    Servier Gy\u00f3gyszerkutat\u00f3 Int\u00e9zet<\/p>\n

    K\u00e9mia \u00e9s farmakol\u00f3gia k\u00e9z a k\u00e9zben a daganatos betegek\u00e9rt<\/em><\/p>\n

    14:45\u00a0\u00a0 K\u00e1v\u00e9sz\u00fcnet<\/strong><\/p>\n

    15:15-17:15\u00a0\u00a0\u00a0\u00a0 \u00dajdons\u00e1gok az onkoter\u00e1pi\u00e1ban-T\u00f6lgyes Terem<\/strong><\/p>\n

    Eln\u00f6k:<\/u> Monostory Katalin, Vastag Monika<\/p>\n

    15:15<\/strong>\u00a0\u00a0 Sz\u00e1ll\u00e1si Zolt\u00e1n<\/strong>1,2<\/sup><\/p>\n

    1<\/sup>Children\u2019s Hospital, Boston 2<\/sup>Semmelweis Egyetem, Budapest<\/p>\n

    A DNS jav\u00edt\u00f3 mechanizmusok hi\u00e1nya, mint ter\u00e1pi\u00e1s c\u00e9lpont a r\u00e1kbetegs\u00e9g kezel\u00e9s\u00e9ben: Diagnosztikus szempontok \u00e9s klinikai hat\u00e9konys\u00e1g<\/em><\/p>\n

    \u00a0<\/em>15:35\u00a0\u00a0 <\/strong>F\u00fcredi Andr\u00e1s1<\/sup><\/strong>, Szeb\u00e9nyi Korn\u00e9lia1<\/sup>, T\u00f3th Szil\u00e1rd1<\/sup>, Gergely Szak\u00e1cs1,2<\/sup><\/p>\n

    1<\/sup>Term\u00e9szettudom\u00e1nyi Kutat\u00f3k\u00f6zpont, Enzimol\u00f3giai Int\u00e9zet, Budapest 2<\/sup>Institute of Cancer Research, Medical University of Vienna, Vienna<\/p>\n

    A ter\u00e1piarezisztencia kikapcsol\u00e1sa tumor sejtekben<\/em><\/p>\n

    \u00a0<\/em>15:55\u00a0\u00a0 <\/strong>Vajdovich P\u00e9ter1<\/sup><\/strong>, F\u00fcredi Andr\u00e1s2<\/sup>, Szeb\u00e9nyi Korn\u00e9lia2<\/sup>, Szak\u00e1cs Gergely2, <\/sup><\/p>\n

    Karai Edina1<\/sup>, Szendi Eszter1<\/sup>, D\u00e9kay Val\u00e9ria1<\/sup>, Miskolczi Mil\u00e1n1<\/sup><\/p>\n

    1<\/sup>\u00c1llatorvostudom\u00e1nyi Egyetem, Budapest 2<\/sup>Term\u00e9szettudom\u00e1nyi Kutat\u00f3k\u00f6zpont, Enzimol\u00f3giai Int\u00e9zet, Budapest<\/p>\n

    Modellvizsg\u00e1latokkal al\u00e1t\u00e1masztott klinikai eredm\u00e9nyek a ter\u00e1piarezisztencia lek\u00fczd\u00e9s\u00e9re kuty\u00e1k daganatos k\u00f3rk\u00e9peinek kezel\u00e9s\u00e9ben<\/em><\/p>\n

    \u00a0<\/em>16:15\u00a0\u00a0 <\/strong>Bir\u00f3 Orsolya<\/strong>1<\/sup>, Kis D\u00e1vid1<\/sup>, Changhoon Chae1,2<\/sup><\/p>\n

    1<\/sup>Clinomics Europe Kft., Budapest 2<\/sup>Clinomics Inc., Ulsan, D\u00e9l-Korea<\/p>\n

    Kering\u0151 tumorsejtek vizsg\u00e1lati lehet\u0151s\u00e9gei \u00e9s alkalmaz\u00e1suk az onkoter\u00e1pi\u00e1ban<\/em><\/p>\n

    \u00a0<\/em>16:30\u00a0\u00a0 <\/strong>Szikriszt Bernadett, P\u00f3ti \u00c1d\u00e1m, N\u00e9meth Eszter, Sz\u00fcts D\u00e1vid<\/strong><\/p>\n

    Term\u00e9szettudom\u00e1nyi Kutat\u00f3k\u00f6zpont, Enzimol\u00f3giai Int\u00e9zet, Budapest Platinaalap\u00fa kemoter\u00e1pi\u00e1s hat\u00f3anyagok mutagenikus hat\u00e1s\u00e1nak \u00f6sszehasonl\u00edt\u00f3 vizsg\u00e1lata sejtkult\u00far\u00e1ban<\/em><\/p>\n

    \u00a0<\/em>16:50<\/strong>\u00a0\u00a0 Szak\u00e1cs Gergely<\/strong>1,2<\/sup><\/p>\n

    1<\/sup>Center for Cancer Research, Medical University of Vienna 2<\/sup>Term\u00e9szettudom\u00e1nyi Kutat\u00f3k\u00f6zpont, Enzimol\u00f3giai Int\u00e9zet, Budapest Ter\u00e1piarezisztens tumorok vizsg\u00e1lata in vitro \u00e9s in vivo modellekben<\/em><\/p>\n

    \u00a0<\/em><\/p>\n

    15:15-17:15\u00a0\u00a0\u00a0\u00a0 A farmakol\u00f3gia, farmakoter\u00e1pia \u00e9s a klinikai farmakol\u00f3gia gradu\u00e1lis <\/strong><\/p>\n

    oktat\u00e1s\u00e1nak aktu\u00e1lis helyzete \u00e9s kih\u00edv\u00e1sai Magyarorsz\u00e1gon – B\u00fckk\u00f6s Terem<\/strong><\/p>\n

    Eln\u00f6k:<\/u> Varga Zolt\u00e1n<\/p>\n

    15:15<\/strong>\u00a0\u00a0 Riba P\u00e1l<\/strong><\/p>\n

    SE Farmakol\u00f3giai \u00e9s Farmakoter\u00e1pi\u00e1s Int\u00e9zet, Budapest<\/p>\n

    A farmakol\u00f3gia oktat\u00e1s\u00e1nak helye \u00e9s helyzete a jelen kih\u00edv\u00e1sok t\u00fckr\u00e9ben a Semmelweis Egyetemen<\/em><\/p>\n

    \u00a0<\/em>15:40\u00a0\u00a0 <\/strong>G\u00f6rbe Anik\u00f3<\/strong>, Varga Zolt\u00e1n<\/p>\n

    SE Farmakol\u00f3giai \u00e9s Farmakoter\u00e1pi\u00e1s Int\u00e9zet, Budapest<\/p>\n

    A klinikai farmakol\u00f3gia oktat\u00e1s\u00e1nak helye \u00e9s helyzete a jelen kih\u00edv\u00e1sok t\u00fckr\u00e9ben Semmelweis Egyetemen<\/em><\/p>\n

    16:05\u00a0\u00a0 <\/strong>Peth\u0151 G\u00e1bor, Pint\u00e9r Erika<\/strong><\/p>\n

    PTE \u00c1OK, Farmakol\u00f3giai \u00e9s Farmakoter\u00e1piai Int\u00e9zet, P\u00e9cs<\/p>\n

    A p\u00e9csi farmakol\u00f3gia-oktat\u00e1s jellegzetess\u00e9gei \u00e9s aktu\u00e1lis kih\u00edv\u00e1sai a P\u00e9csi Tudom\u00e1nyegyetem<\/em><\/p>\n

    16:30\u00a0\u00a0 <\/strong>Orosz Andrea<\/strong><\/p>\n

    Farmakol\u00f3giai \u00e9s Farmakoter\u00e1piai Int\u00e9zet, Szent-Gy\u00f6rgyi Albert Orvostudom\u00e1nyi Kar, Szegedi Tudom\u00e1nyegyetem<\/p>\n

    Farmakol\u00f3gia gradu\u00e1lis oktat\u00e1sa a Szegedi Tudom\u00e1nyegyetemen<\/em><\/p>\n

    16:55<\/strong>\u00a0\u00a0 P\u00f3rsz\u00e1sz R\u00f3bert Krist\u00f3f<\/strong><\/p>\n

    DE Farmakol\u00f3giai \u00e9s Farmakoter\u00e1piai Int\u00e9zet, Debrecen<\/p>\n

    Farmakol\u00f3gia gradu\u00e1lis oktat\u00e1sa a Debreceni Egyetemen<\/em><\/p>\n

     <\/p>\n

    17:15\u00a0\u00a0 K\u00e1v\u00e9sz\u00fcnet<\/strong><\/p>\n

     <\/p>\n

    17:30-19:15\u00a0\u00a0\u00a0\u00a0 Issekutz-el\u0151ad\u00e1sok- T\u00f6lgyes terem<\/strong><\/p>\n

    Eln\u00f6k:<\/u> Helyes Zsuzsanna<\/p>\n

    17:30\u00a0\u00a0 Zupk\u00f3 Istv\u00e1n <\/strong><\/p>\n

    Szegedi Tudom\u00e1nyegyetem<\/p>\n

    Utam a gy\u00f3gyszerhat\u00e1stanban: az izom-elektrofiziol\u00f3gi\u00e1t\u00f3l az in vitro tumorfarmakol\u00f3gi\u00e1ig<\/em><\/p>\n

    17:55\u00a0\u00a0 Sz\u00f6k\u0151 \u00c9va <\/strong><\/p>\n

    Semmelweis Egyetem Gy\u00f3gyszerhat\u00e1stani Int\u00e9zet<\/p>\n

    A kapill\u00e1ris elektrofor\u00e9zis esete a farmakol\u00f3gi\u00e1val<\/em><\/p>\n

    \u00a0<\/em><\/p>\n

    18:15\u00a0\u00a0 Issekutz D\u00edj\u00e1tad\u00e1s<\/strong><\/p>\n

     <\/p>\n

    19:15\u00a0\u00a0 Vacsora-AVAR Hotel **** superior \u00c9tterem<\/strong><\/p>\n

     <\/p>\n

    20:30 \u00a0 Vereczkey L\u00e1szl\u00f3 80. sz\u00fclet\u00e9snapi k\u00f6sz\u00f6nt\u00e9se- T\u00f6lgyes terem<\/strong><\/p>\n

    Eln\u00f6k<\/u>: Monostory Katalin<\/p>\n

    20.40\u00a0\u00a0 Esti Kerekasztal- <\/strong>Meglep\u0151 eredm\u00e9nyek-Meglep\u0151 magyar\u00e1zatok- T\u00f6lgyes terem<\/strong><\/p>\n

    Eln\u00f6k:<\/u> Vereczkey L\u00e1szl\u00f3<\/p>\n

    Vajda Fl\u00f3ra<\/strong><\/p>\n

    Term\u00e9szettudom\u00e1nyi Kutat\u00f3k\u00f6zpont, Budapest<\/p>\n

    Kett\u0150S \u00fcgyn\u00f6k a kemoter\u00e1pi\u00e1ban<\/em><\/p>\n

    Incze Evelyn<\/strong><\/p>\n

    Term\u00e9szettudom\u00e1nyi Kutat\u00f3k\u00f6zpont, Budapest<\/p>\n

    Mit CYP-elnek a daganat-sejtek?<\/em><\/p>\n

    \u00a0<\/strong><\/p>\n

      \n
    1. j\u00fanius 8. (szerda)<\/strong><\/li>\n<\/ol>\n

      07:00-07:30 \u00a0\u00a0 Greiner <\/strong>Reggeli Fut\u00e1s<\/p>\n

       <\/p>\n

      08:00\u00a0\u00a0 Regisztr\u00e1ci\u00f3<\/strong><\/p>\n

       <\/p>\n

      09:00-11:00\u00a0\u00a0\u00a0\u00a0 In vitro – in vivo modellek, \u00faj fejleszt\u00e9si elj\u00e1r\u00e1sok<\/strong>– T\u00f6lgyes Terem<\/strong><\/p>\n

      Eln\u00f6k<\/u>: Orb\u00e1n Tam\u00e1s, Ap\u00e1ti \u00c1gota<\/p>\n

      09:00<\/strong>\u00a0\u00a0 Csala Mikl\u00f3s<\/strong><\/p>\n

      Semmelweis Egyetem, Molekul\u00e1ris Biol\u00f3giai Tansz\u00e9k, Budapest<\/p>\n

      Lipotoxicit\u00e1s vizsg\u00e1lata hasny\u00e1lmirigy <\/em>b<\/em>-sejt \u00e9s m\u00e1jsejt eredet\u0171 sejtvonalakban<\/em><\/p>\n

      09:20<\/strong>\u00a0\u00a0 Hoffmann Orsolya Ivett<\/strong>1<\/sup>, Hiripi L\u00e1szl\u00f31<\/sup>, Bender Bal\u00e1zs2<\/sup>, Bodrogi Lilla1<\/sup>,G\u00f3cza Elen1<\/sup><\/p>\n

      1<\/sup>Magyar Agr\u00e1r- \u00e9s \u00c9lettudom\u00e1nyi Egyetem, Genetika \u00e9s Biotechnol\u00f3gia Int\u00e9zet, \u00c1llatbiotechnol\u00f3gia Tansz\u00e9k, G\u00f6d\u00f6ll\u0151 2<\/sup>Immunogenes-ABS Zrt., Budakeszi<\/p>\n

      Genetikailag m\u00f3dos\u00edtott ny\u00falmodellek l\u00e9trehoz\u00e1sa \u00e9s felhaszn\u00e1l\u00e1sa<\/em><\/p>\n

      09:40\u00a0\u00a0 <\/strong>D\u00e9ri M\u00e1t\u00e9<\/strong>1<\/sup>, Fekete Ferenc1<\/sup>, Szatm\u00e1ry Zs\u00f3fia Anna1<\/sup>, Hirka Bogl\u00e1rka1<\/sup>, Szak\u00e1l-T\u00f3th Zs\u00f3fia2<\/sup>, Sax Bal\u00e1zs2<\/sup>, Monostory Katalin1<\/sup><\/p>\n

      1<\/sup>Term\u00e9szettudom\u00e1nyi Kutat\u00f3k\u00f6zpont, Budapest 2<\/sup>Semmelweis Egyetem, V\u00e1rosmajori Sz\u00edv- \u00e9s \u00c9rgy\u00f3gy\u00e1szati Klinika, Budapest<\/p>\n

      Immunszuppresszi\u00f3s hat\u00e9konys\u00e1gbecsl\u00e9s sz\u00edvtranszplant\u00e1lt betegekn\u00e9l<\/em><\/p>\n

      09:50\u00a0\u00a0 <\/strong>Lily M Park1<\/sup>, Joanne Lannigan2<\/sup>,\u00a0Maria C Jaimes\u00a0<\/sup>1<\/sup>, Csaba Bank\u00f3<\/strong>3<\/sup><\/p>\n

      1<\/sup>Research and Development, Cytek Biosciences, Inc., Fremont, California, USA 2<\/sup>Flow Cytometry Support Services, LLC, Alexandria, Virginia, USA 3<\/sup>BioTech Hungary Kft., Szigetszentmikl\u00f3s<\/p>\n

      Analiz\u00e1ljon \u00e9s sortoljon ak\u00e1r 40 marker alapj\u00e1n a Cytek spektr\u00e1lis technol\u00f3gi\u00e1val<\/em><\/p>\n

      10:00<\/strong>\u00a0\u00a0 Szeb\u00e9nyi Korn\u00e9lia<\/strong>1,2<\/sup>, Lakatos Andr\u00e1s2<\/sup><\/p>\n

      1<\/sup>Term\u00e9szettudom\u00e1nyi Kutat\u00f3k\u00f6zpont, Enzimol\u00f3giai Int\u00e9zet, Budapest 2<\/sup>University of Cambridge, Cambridge<\/p>\n

      Organoid modellek a gy\u00f3gyszer-fejleszt\u00e9sben<\/em><\/p>\n

      10:20\u00a0\u00a0 <\/strong>On\u00f3di Zs\u00f3fia<\/strong>1,2,3<\/sup>, Visnovitz Tam\u00e1s4<\/sup>, Kiss Bernadett1,5<\/sup>, Koncz Anna4<\/sup>,<\/p>\n

      \u00c1gg Bence1,5,8<\/sup>, V\u00e1radi Barnab\u00e1s1<\/sup>, T\u00f3th Vikt\u00f3ria \u00c9.1,2,3<\/sup>, Gerg\u0151 Dorottya1,2<\/sup>, Makkos Andr\u00e1s1,5<\/sup>, Pelyhe Csilla1<\/sup>, Varga N\u00f3ra6<\/sup>, Re\u00e9 D\u00f3ra6<\/sup>, Ap\u00e1ti \u00c1gota6<\/sup>, Leszek Przemyslaw7<\/sup>, Kov\u00e1cs Tam\u00e1s11<\/sup>, Nagy N\u00e1ndor11<\/sup>, Ferdinandy P\u00e9ter1,5,8<\/sup>, Buz\u00e1s Edit I.4,9,10<\/sup>, G\u00f6rbe Anik\u00f31,5,8<\/sup>, Giricz Zolt\u00e1n1,5,8<\/sup>, Varga Zolt\u00e1n V.1,2,3<\/sup><\/p>\n

      1<\/sup>Semmelweis Egyetem Farmakol\u00f3giai \u00e9s Farmakoter\u00e1pi\u00e1s Int\u00e9zet, Budapest 2<\/sup>HCEMM-SE Kardiometabolikus Immunol\u00f3gia Kutat\u00f3csoport, Budapest 3<\/sup>MTA-SE Lend\u00fclet Kardioonkol\u00f3gia \u00e9s Kardioimmunol\u00f3gia Kutat\u00f3csoport, Budapest 4<\/sup>Semmelweis Egyetem Genetikai, Sejt- \u00e9s Immunbiol\u00f3giai Int\u00e9zet, Budapest 5<\/sup>MTA-SE Rendszerfarmakol\u00f3giai Kutat\u00f3csoport, Semmelweis Egyetem Farmakol\u00f3giai \u00e9s Farmakoter\u00e1pi\u00e1s Int\u00e9zet, Budapest 6<\/sup>ELKH-Term\u00e9szettudom\u00e1nyi Kutat\u00f3int\u00e9zet Enzimol\u00f3giai Int\u00e9zet, Budapest 7<\/sup>Cardinal Stefan Wyszy\u0144ski Nemzeti Kardiol\u00f3giai Int\u00e9zet, Vars\u00f3, Lengyelorsz\u00e1g 8<\/sup>Pharmahungary Csoport, Szeged 9<\/sup>ELKH-SE Immunproteogenomikai Kutat\u00f3csoport, Budapest 10<\/sup>HCEMM-SE Extracellul\u00e1ris Vezikula Kutat\u00f3csoport, Budapest 11<\/sup>Semmelweis Egyetem Anat\u00f3miai, Sz\u00f6vet- \u00e9s Fejl\u0151d\u00e9stani Int\u00e9zet, Budapest<\/p>\n

      A kardiovaszkul\u00e1ris kutat\u00e1sban alkalmazott sejtvonalak \u00e9s primer sejtkult\u00far\u00e1k \u00f6sszehasonl\u00edt\u00f3 vizsg\u00e1lata<\/em><\/p>\n

      10:30<\/strong>\u00a0\u00a0 Vincze Katalin<\/strong>1,3<\/sup>, Szab\u00f3 Eszter1<\/sup>, Re\u00e9 D\u00f3ra1<\/sup>, Jezs\u00f3 B\u00e1lint1<\/sup>, Tordai Csongor 3<\/sup>,<\/p>\n

      Moln\u00e1r \u00c1. Andrea2<\/sup>, R\u00e9thelyi M. J\u00e1nos 3,4<\/sup>, Ap\u00e1ti \u00c1gota1<\/sup><\/p>\n

      1<\/sup>Enzimol\u00f3giai Int\u00e9zet, Term\u00e9szettudom\u00e1nyi Kutat\u00f3k\u00f6zpont, E\u00f6tv\u00f6s Lor\u00e1nd Kutat\u00e1si H\u00e1l\u00f3zat, Budapest 2<\/sup>Sz\u00edv- \u00e9s \u00c9rgy\u00f3gy\u00e1szati K\u00f6zpont, Semmelweis Egyetem, Budapest 3<\/sup>Molekul\u00e1ris Pszichi\u00e1triai Kutat\u00f3csoport, Nemzeti Agykutat\u00e1si Program (NAP), Magyar Tudom\u00e1nyos Akad\u00e9mia \u00e9s Semmelweis Egyetem, Budapest 4<\/sup>Pszichi\u00e1triai \u00e9s Pszichoter\u00e1pi\u00e1s Klinika, Semmelweis Egyetem, Budapest<\/p>\n

      \u00a0A II t\u00edpus\u00fa diabetes in vitro modellez\u00e9se<\/em><\/p>\n

      10:40<\/strong>\u00a0\u00a0 Nagy Andr\u00e1s<\/strong><\/p>\n

      Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, Kanada<\/p>\n

      \u0150ssejt alap\u00fa passz\u00edv immuniz\u00e1ci\u00f3 a COVID-19 elleni v\u00e9dekez\u00e9sben<\/em><\/p>\n

       <\/p>\n

      09:00-11:00\u00a0\u00a0\u00a0\u00a0 NO- and H2<\/sub>S-releasing molecules as potential therapeutics in <\/strong>inflammation and cardiovascular diseases \u2013 B\u00fckk\u00f6s Terem\u00a0 <\/strong><\/p>\n

      Eln\u00f6k:<\/u> Borb\u00e1s Anik\u00f3, Marcin Magierowski<\/p>\n

      09:00\u00a0\u00a0 <\/strong>Beltowski Jerzy<\/strong>1<\/sup>, Wi\u00f3rkowski Krzysztof2<\/sup>, Kowalczyk-Boltuc Jolanta3<\/sup><\/p>\n

      1<\/sup>Department of Pathophysiology, Medical University of Lublin, Lublin, Poland 2<\/sup>Care Unit, Luxmed Lublin Medical Center\u2014Primary, Lublin, Poland 3<\/sup>Endocrinology and Metabolism Clinic, Internal Medicine Clinic with Hypertension Department, Medical Institute of Rural Health, Lublin, Poland<\/p>\n

      The effect of H2<\/sub>S and polysulfides on adipose tissue metabolism and insulin sensitivity in lean and obese rats<\/em><\/p>\n

      09:24<\/strong>\u00a0\u00a0 Ilona Bereczki1<\/sup>, Mikl\u00f3s Lovas1<\/sup>, \u00c1rp\u00e1d T\u00f3saki2<\/sup>, Anik\u00f3 Borb\u00e1s1<\/sup>, P\u00e1l Herczegh<\/strong>1<\/sup><\/p>\n

      1<\/sup>Department of Pharmaceutical Chemistry, University of Debrecen 2<\/sup>Department of Pharmacology, University of Debrecen<\/p>\n

      Design and synthesis of NO- and H2<\/sub>S-releasing NSAIDs<\/em><\/p>\n

      09:48 <\/strong>\u00a0 Istv\u00e1n Lekli<\/strong>1<\/sup>, Alexandra Gy\u00f6ngy\u00f6si1<\/sup>, Kitti Sz\u0151ke1<\/sup>, Ilona Bereczki2<\/sup>, Anik\u00f3 Borb\u00e1s2<\/sup>, \u00c1rp\u00e1d T\u00f3saki1<\/sup>, P\u00e1l Herczegh2<\/sup><\/p>\n

      1<\/sup>Department of Pharmacology, Faculty of Pharmacy, University of Debrecen 2<\/sup>Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Debrecen<\/p>\n

      Pharmacological study of hydrogen sulfide and nitrogen monoxide donor NSAIDs<\/em><\/p>\n

      10:12\u00a0\u00a0 <\/strong>Katarzyna Magierowska1<\/sup>, Edyta Korbut1<\/sup>, Dagmara W\u00f3jcik-Grzybek1<\/sup>, Kinga<\/p>\n

      Krukowska1<\/sup>, Urszula G\u0142owacka1<\/sup>, Dominik Bakalarz1<\/sup>, Tomasz Brzozowski1<\/sup>, John L Wallace2<\/sup>, Binghe Wang3<\/sup>, Matthew Whiteman4<\/sup>, Marcin Magierowski<\/strong>1<\/sup><\/p>\n

      1<\/sup>Cellular Engineering and Isotope Diagnostics Laboratory, Department of Physiology, Jagiellonian University Medical College, Krakow, Poland 2<\/sup>University of Calgary, Calgary, Canada 3<\/sup>Department of Chemistry, Georgia State University, Atlanta, USA 4<\/sup>University of Exeter Medical School, Exeter, The United Kingdom<\/p>\n

      Gaseous mediators-releasing prodrugs vs acute and chronic pathologies of upper gastrointestinal tract<\/em><\/p>\n

      \u00a0<\/em>10:36\u00a0\u00a0 <\/strong>Pint\u00e9r Erika<\/strong>1<\/sup>, B\u00e1tai Istv\u00e1n Zo\u00e1rd1<\/sup>, Dombi \u00c1gnes, Horv\u00e1th \u00c1d\u00e1m Istv\u00e1n1<\/sup>, Sz\u0151ke<\/p>\n

      \u00c9va1<\/sup>, Borb\u00e9ly \u00c9va1<\/sup>, S\u00e1ndor Zolt\u00e1n1<\/sup> M\u00f3csai Attila2<\/sup>, Feh\u00e9r \u00c1d\u00e1m3<\/sup>, Papp Ferenc3<\/sup>, Pozsgai G\u00e1bor1<\/sup><\/p>\n

      1<\/sup>Farmakol\u00f3giai \u00e9s Farmakoter\u00e1piai Int\u00e9zet, \u00c1ltal\u00e1nos Orvostudom\u00e1nyi Kar, P\u00e9csi Tudom\u00e1nyegyetem 2<\/sup>\u00c9lettani Int\u00e9zet, Semmelweis Egyetem, Budapest 3<\/sup>Biofizikai Int\u00e9zet, \u00c1ltal\u00e1nos Orvostudom\u00e1nyi Kar, Debreceni Egyetem<\/p>\n

      TRPA1 receptor mediated effects of hydrogen sulfide<\/em><\/p>\n

       <\/p>\n

      11:00 \u00a0 K\u00e1v\u00e9sz\u00fcnet<\/strong><\/p>\n

       <\/p>\n

      11:20-13:20\u00a0\u00a0\u00a0\u00a0 A gy\u00f3gyszermetabolizmus analitik\u00e1ja- T\u00f6lgyes Terem
      \n<\/strong>Eln\u00f6k:<\/u> Szab\u00f3 P\u00e1l, Sz\u00e1ntay Csaba<\/p>\n

      11:20\u00a0\u00a0 <\/strong>Kirschner Norbert<\/strong><\/p>\n

      Fejleszt\u00e9si gy\u00f3gyszer-metabolizmus \u00e9s farmakokinetika oszt\u00e1ly, Richter Gedeon NyRt., Budapest<\/p>\n

      Izot\u00f3pok, izomerek, izob\u00e1rok \u2013 gy\u00f3gyszermetabolitok detekt\u00e1l\u00e1sa \u00e9s szerkezetazonos\u00edt\u00e1sa nagyfelbont\u00e1s\u00fa t\u00f6megspektrometri\u00e1val<\/em><\/p>\n

      11:40\u00a0\u00a0 <\/strong>K\u00e1lomista Ildik\u00f3<\/strong><\/p>\n

      In-vitro Metabolizmus Laborat\u00f3rium, Richter Gedeon Nyrt, Budapest<\/p>\n

      In vitro ADME kih\u00edv\u00e1sok, bioanalitikai feladatok<\/em><\/p>\n

      12:00\u00a0\u00a0 <\/strong>Hegyin\u00e9 Kemenes Klaudia<\/strong>1<\/sup>, Hidv\u00e9gi El\u0151d1<\/sup>, S\u00fcvegh G\u00e1bor1<\/sup><\/p>\n

      1<\/sup>NSZKK Toxikol\u00f3giai Szak\u00e9rt\u0151i Int\u00e9zet, Budapest<\/p>\n

      Az UHPLC-QToF-ban rejl\u0151 lehet\u0151s\u00e9gek a k\u00e1b\u00edt\u00f3szerek metabolizmus\u00e1nak vizsg\u00e1lat\u00e1ban<\/em><\/p>\n

      \u00a0<\/em>12:20\u00a0\u00a0 <\/strong>Magda Bal\u00e1zs<\/strong>, Cs\u00edkv\u00e1ri Oliv\u00e9r, M\u00f3ricz-Sur\u00e1nyi Katalin, Varga B\u00e1lint<\/p>\n

      EGIS Gy\u00f3gyszergy\u00e1r Zrt., Budapest<\/p>\n

      J\u00e1rt utat a j\u00e1ratlan\u00e9rt…? Kombin\u00e1ci\u00f3s k\u00e9sz\u00edtm\u00e9ny hat\u00f3anyagainak mennyis\u00e9gi meghat\u00e1roz\u00e1sa az SLE (Supported Liquid Extraction) mintael\u0151k\u00e9sz\u00edt\u00e9s \u00e1rnyoldalainak t\u00fckr\u00e9ben<\/em><\/p>\n

      \u00a0<\/em><\/strong>12:40<\/strong>\u00a0\u00a0 Darcsi Andr\u00e1s<\/strong><\/p>\n

      Orsz\u00e1gos Gy\u00f3gyszer\u00e9szeti \u00e9s \u00c9lelmez\u00e9s-eg\u00e9szs\u00e9g\u00fcgyi Int\u00e9zet, Laborat\u00f3riumi F\u0151oszt\u00e1ly, Gy\u00f3gyszerk\u00e9miai \u00e9s Technol\u00f3giai Laborat\u00f3rium, Budapest<\/p>\n

      A t\u00f6megspektrometria gyakorlati alkalmaz\u00e1sai az OGY\u00c9I hat\u00f3s\u00e1gi gy\u00f3gyszervizsg\u00e1l\u00f3 laborat\u00f3rium\u00e1ban<\/em><\/p>\n

      \u00a0<\/em>13:00\u00a0\u00a0 Diszkusszi\u00f3<\/strong><\/p>\n

      \u00a0<\/strong><\/p>\n

      11:20-13:20\u00a0\u00a0\u00a0\u00a0 Novel insights into the pathogenesis and treatment of <\/strong>gastrointestinal and pancreatic diseases – B\u00fckk\u00f6s Terem<\/strong><\/p>\n

      Eln\u00f6k:<\/u> Kl\u00e1ra Gyires, Vikt\u00f3ria Venglovecz, Zolt\u00e1n S. Z\u00e1dori<\/p>\n

      11:20<\/strong>\u00a0\u00a0 Tomasz Brzozowski<\/strong><\/p>\n

      Department of Physiology Jagiellonian University Medical College, Cracow, Poland<\/p>\n

      Non-conventional methods of therapy against the inflammatory bowel disease (IBD). Evidence from experimental and clinical studies<\/em><\/p>\n

      11:50\u00a0\u00a0 <\/strong>Venglovecz Vikt\u00f3ria<\/strong>1<\/sup>, Grassalkovich Anna2<\/sup>, T\u00f3th Emese2<\/sup>, Mal\u00e9th J\u00f3zsef2<\/sup>,Hegyi P\u00e9ter2,3,4<\/sup><\/p>\n

      1<\/sup>Department of Pharmacology and Pharmacotherapy, University of Szeged 2<\/sup>First Department of Medicine, University of Szeged 3<\/sup>Institute for Translational Medicine, University of P\u00e9cs 4<\/sup>Centre for Translational Medicine and Division for Pancreatic Disorders, Semmelweis University, Budapest<\/p>\n

      Restoration of CFTR function decreases the severity of acute pancreatitis<\/em><\/p>\n

      12:10\u00a0\u00a0 <\/strong>Zolt\u00e1n S. Z\u00e1dori<\/strong>1<\/sup>, Barbara Hutka1<\/sup>, Andr\u00e1s S. T\u00f3th1<\/sup>, Szilvia B. L\u00e1szl\u00f31<\/sup>, Anett V\u00e1rallyay1<\/sup>, Andrea Balogh2<\/sup>, Zolt\u00e1n Beny\u00f32<\/sup>, Kl\u00e1ra Gyires1<\/sup><\/p>\n

      1<\/sup>Department of Pharmacology and Pharmacotherapy, Semmelweis University, Budapest 2<\/sup>Institute of Translational Medicine, Semmelweis University, Budapest<\/p>\n

      Seeking new options for the treatment of NSAID enteropathy<\/em><\/p>\n

      12:30\u00a0\u00a0 <\/strong>B\u00e1lint T\u00e9l 1,2<\/sup>, No\u00e9mi Papp2<\/sup>, Barnab\u00e1s De\u00e1k2<\/sup>, G\u00e1bor Veres\u2020 3<\/sup>, J\u00f3zsef Mal\u00e9th 2<\/sup>,Petra Pallagi<\/strong>2<\/sup><\/p>\n

      1 <\/sup>First Department of Paediatrics, Semmelweis University, Budapest 2<\/sup> First Department of Medicine, University of Szeged 3<\/sup> Paediatric Institute-Clinic, University of Debrecen<\/p>\n

      Investigating the background of inflammatory bowel disease-associated pancreatic damage<\/em><\/p>\n

      12:50<\/strong>\u00a0\u00a0 Docsa Tibor, Turarova Botagoz, Uray Karen<\/strong><\/p>\n

      University of Debrecen, Faculty of Medicine, Department of Medical Chemistry, Debrecen<\/p>\n

      Mechanotransduction in the development of ileus: the role of HCN2<\/em><\/p>\n

      \u00a0<\/em><\/p>\n

      13:20\u00a0\u00a0 Eb\u00e9d-AVAR Hotel **** superior \u00c9tterem<\/strong><\/p>\n

       <\/p>\n

      14:20-15:30\u00a0\u00a0\u00a0\u00a0 Poszter szekci\u00f3- B\u00fckk\u00f6s Terem I.<\/strong><\/p>\n

      \u00a0<\/strong><\/p>\n

      15:30\u00a0\u00a0 K\u00e1v\u00e9sz\u00fcnet<\/strong><\/p>\n

      \u00a0<\/em><\/p>\n

      15:50-17:50\u00a0\u00a0\u00a0\u00a0 Gy\u00f3gyszerinnov\u00e1ci\u00f3- T\u00f6lgyes Terem\u00a0\u00a0\u00a0 <\/strong><\/p>\n

      Eln\u00f6k:<\/u> L\u00e9vay Gy\u00f6rgy, Lendvai Bal\u00e1zs<\/p>\n

      15:50<\/strong>\u00a0\u00a0 Orb\u00e1n I. Tam\u00e1s<\/strong><\/p>\n

      Enzimol\u00f3giai Int\u00e9zet, Term\u00e9szettudom\u00e1nyi Kutat\u00f3k\u00f6zpont, Budapest<\/p>\n

      A mikroRNS-alap\u00fa szab\u00e1lyoz\u00e1si h\u00e1l\u00f3zatok vizsg\u00e1lata betegs\u00e9gmodellekben<\/em><\/p>\n

      16:10\u00a0\u00a0 <\/strong>Z\u00e1dor Ferenc<\/strong>1, a<\/sup>, Nagy-Gr\u00f3cz G\u00e1bor2,3<\/sup>, Dvor\u00e1csk\u00f3 Szabolcs1<\/sup>, Benyhe S\u00e1ndor1<\/sup>,V\u00e9csei L\u00e1szl\u00f33,4<\/sup><\/p>\n

      1<\/sup>Biok\u00e9miai Int\u00e9zet, Szegedi Biol\u00f3giai Kutat\u00f3k\u00f6zpont, Szeged 2<\/sup>Eg\u00e9szs\u00e9gtudom\u00e1nyi \u00e9s Szoci\u00e1lis K\u00e9pz\u00e9si Kar, Szegedi Tudom\u00e1nyegyetem, Szeged 3<\/sup>Neurol\u00f3giai Klinika, Szent-Gy\u00f6rgyi Albert Klinikai K\u00f6zpont, Szegedi Tudom\u00e1nyegyetem, Szeged 4<\/sup>ELKH-SZTE Idegtudom\u00e1nyi Kutat\u00f3csoport, Szeged a<\/sup>Jelenlegi munkahely: Farmakol\u00f3giai \u00e9s Gy\u00f3gyszerbiztons\u00e1gi Kutat\u00e1si F\u0151oszt\u00e1ly, Richter Gedeon Nyrt., Budapest<\/p>\n

      Az endokannabinoid rendszer \u00e9s a kinurenin \u00fatvonal kapcsolata a k\u00f6zponti idegrendszeri megbeteged\u00e9sekben<\/em><\/p>\n

      \u00a0<\/em>16:30\u00a0\u00a0 <\/strong>\u00dcrm\u00f6si Ad\u00e9l1<\/sup>, Vincze Vir\u00e1g2<\/sup>, Szab\u00f3 Zs\u00f3fia Borb\u00e1la1<\/sup>, Juh\u00e1sz G\u00e1bor1,2<\/sup>, Szab\u00f3 <\/strong>\u00c1ron<\/strong>1<\/sup><\/p>\n

      1<\/sup>ELKH Szegedi Biol\u00f3giai Kutat\u00f3k\u00f6zpont, Genetikai Int\u00e9zet, Szeged<\/p>\n

      2<\/sup>ELTE TTK, Anat\u00f3miai, Sejt- \u00e9s Fejl\u0151d\u00e9sbiol\u00f3giai Tansz\u00e9k, Budapest<\/p>\n

      LC3-asszoci\u00e1lt fagocit\u00f3zis az idegrendszerben: egy lehets\u00e9ges ter\u00e1pi\u00e1s c\u00e9lpont neurodegenerat\u00edv betegs\u00e9gekben?<\/em><\/p>\n

      \u00a0<\/em>16:50\u00a0\u00a0 <\/strong>Top\u00e1l J\u00f3zsef<\/strong><\/p>\n

      Term\u00e9szettudom\u00e1nyi Kutat\u00f3k\u00f6zpont, Kognit\u00edv Idegtudom\u00e1nyi \u00e9s Pszichol\u00f3giai Int\u00e9zet, Budapest<\/p>\n

      A kutya, mint az autizmus egy lehets\u00e9ges transzl\u00e1ci\u00f3s modellje – egy hossz\u00fa \u00fat els\u0151 l\u00e9p\u00e9sei<\/em><\/p>\n

      17:10\u00a0 <\/strong>Kelemen Krist\u00f3f<\/strong><\/p>\n

      Richter Gedeon Nyrt., Budapest<\/p>\n

      G\u00e9pi tanul\u00f3 elj\u00e1r\u00e1sok felhaszn\u00e1l\u00e1sa a farmakol\u00f3giai vizsg\u00e1latok ki\u00e9rt\u00e9kel\u00e9s\u00e9re<\/em><\/p>\n

      \u00a0<\/em>17:30\u00a0\u00a0 <\/strong>Zsolt N\u00e9methy<\/strong><\/p>\n

      Pharmacology and Drug Safety Research, Gedeon Richter Plc.<\/p>\n

      Convergent cross-species pro-cognitive effects of RGH-235, a new potent and selective histamine H3 receptor antagonist\/inverse agonist<\/em><\/p>\n

      \u00a0<\/em><\/p>\n

      15:50-17:50\u00a0\u00a0\u00a0\u00a0 Sensory neuropharmacology\/ Szenzoros neurofarmakol\u00f3gia- B\u00fckk\u00f6s-Terem<\/strong><\/p>\n

      Eln\u00f6k:<\/u> Helyes Zsuzsanna, Zelles Tibor<\/p>\n

      15:50 \u00c9va Borb\u00e9ly<\/strong>1<\/sup>, Zsuzsanna Helyes1<\/sup>,2,3<\/sup><\/p>\n

      1<\/sup> Department of Pharmacology and Pharmacotherapy, Medical School & J\u00e1nos Szent\u00e1gothai Research Center, University of P\u00e9cs 2<\/sup>PharmInVivo Ltd, P\u00e9cs 3<\/sup>Algonist Gmbh, Wien, Austria<\/p>\n

      Drug development perspectives of Transient Receptor Potential Vanilloid 1 and Ankyrin 1 receptors<\/em><\/p>\n

      \u00a0<\/em>16:14\u00a0\u00a0 <\/strong>Garami Andr\u00e1s<\/strong><\/p>\n

      P\u00e9csi Tudom\u00e1nyegyetem \u00c1ltal\u00e1nos Orvostudom\u00e1nyi Kar Transzl\u00e1ci\u00f3s Medicina Int\u00e9zet Termofiziol\u00f3gia Tansz\u00e9k, P\u00e9cs<\/p>\n

      A tranziens receptor potenci\u00e1l vanilloid-1 csatorna antagonist\u00e1i \u00e1ltal okozott testh\u0151m\u00e9rs\u00e9kleti hat\u00e1sok kiv\u00e9d\u00e9se<\/em><\/p>\n

      \u00a0<\/em><\/strong>16:38<\/strong>\u00a0\u00a0 Regl\u0151di D\u00f3ra<\/strong>1<\/sup>, Tam\u00e1s Andrea1<\/sup>, V\u00e1czy Alexandra1<\/sup>, Szab\u00f3 Edina1<\/sup>, F\u00e1bi\u00e1n Eszter1<\/sup>,<\/p>\n

      Patk\u00f3 Evelin1<\/sup>, D\u00e9nes Di\u00e1na1<\/sup>, Li Lina1<\/sup>, Molitor Dorottya1<\/sup>, F\u00fcl\u00f6p Bal\u00e1zs1<\/sup>, Pham D\u00e1niel1<\/sup>, Atlasz Tam\u00e1s1,2<\/sup><\/p>\n

      1<\/sup>MTA-PTE PACAP Kutat\u00f3csoport, PTE \u00c1OK Anat\u00f3miai Int\u00e9zet \u00e9s Szent\u00e1gothai Kutat\u00f3k\u00f6zpont, P\u00e9cs 2<\/sup>Sportbiol\u00f3giai Int\u00e9zet, PTE TTK, P\u00e9cs<\/p>\n

      A PACAP v\u00e9d\u0151 hat\u00e1sai a l\u00e1t\u00f3- \u00e9s hall\u00f3rendszerben<\/em><\/p>\n

      \u00a0<\/em>17:02\u00a0\u00a0 <\/strong>Tam\u00e1s Kov\u00e1cs-\u00d6ller<\/strong>1,2<\/sup>, Bogl\u00e1rka Balogh1,3<\/sup>, Gergely Szarka1,3<\/sup>, B\u00e9la V\u00f6lgyi1,2,3<\/sup><\/p>\n

      1<\/sup>P\u00e9csi Tudom\u00e1nyegyetem, Szent\u00e1gothai J\u00e1nos Kutat\u00f3k\u00f6zpont, P\u00e9cs 2<\/sup>P\u00e9csi Tudom\u00e1nyegyetem, \u00c1ltal\u00e1nos Orvostudom\u00e1nyi Kar, P\u00e9cs 3<\/sup>P\u00e9csi Tudom\u00e1nyegyetem, Term\u00e9szettudom\u00e1nyi Kar, P\u00e9cs<\/p>\n

      Microglia activation, as a retinal biomarker<\/em><\/p>\n

      \u00a0<\/em>17:26\u00a0\u00a0 <\/strong>Zelles Tibor<\/strong>1,2,3<\/sup>, Szepesy Judit1,2<\/sup>, Humli Vikt\u00f3ria1,2<\/sup>, Farkas J\u00e1nos1,2<\/sup>, Mikl\u00f3s Gabriella2<\/sup>, Berekm\u00e9ri Eszter4<\/sup>, Aller M\u00e1t\u00e95<\/sup>, Horv\u00e1th Tam\u00e1s6<\/sup>, Polony G\u00e1bor7<\/sup>, G\u00e1borj\u00e1n Anita7<\/sup>, Szirmai \u00c1gnes7<\/sup>, T\u00e1m\u00e1s L\u00e1szl\u00f37<\/sup>, F\u00fcl\u00f6p D. Bal\u00e1zs8<\/sup>, Tam\u00e1s Andrea8<\/sup>, Regl\u0151di D\u00f3ra8<\/sup>, Varga Zolt\u00e1n V.2<\/sup>, Fekete \u00c1d\u00e1m9<\/sup>, K\u00f6les L\u00e1szl\u00f31,2<\/sup>, Sperl\u00e1gh Be\u00e1ta3<\/sup>, Vizi E. Szilveszter3<\/sup><\/p>\n

      1<\/sup>Dept. Oral Biology, Semmelweis University, Budapest 2<\/sup>Dept. Pharmacology & Pharmacotherapy, Semmelweis University, Budapest 3<\/sup>Laboratory of Molecular Pharmacology, Institute of Experiment al Medicine, Budapest 4<\/sup>Department of Ecology, University of Veterinary Medicine, Budapest 5<\/sup>MRC Cognition and Brain Sciences Unit, University of Cambridge, Cambridge 6<\/sup>Dept. Otorhinolaryngology, Head and Neck Surgery, Bajcsy-Zsilinszky Hospital, Budapest 7<\/sup>Dept. Otorhinolaryngology, Head and Neck Surgery, Semmelweis University, Budapest 8<\/sup>Dept. Anatomy, University of P\u00e9cs Medical School, P\u00e9cs 9<\/sup>Program in Neurosciences and Mental Health, The Hospital for Sick Children, Toronto<\/p>\n

      Hearing and hearing losses – hunt for effective drug therapy<\/em><\/p>\n

       <\/p>\n

      19:00\u00a0\u00a0 G\u00e1lavacsora -AVAR Hotel **** superior \u00c9tterem<\/strong><\/p>\n

       <\/p>\n

        \n
      1. j\u00fanius 9. (cs\u00fct\u00f6rt\u00f6k)<\/strong><\/li>\n<\/ol>\n

        07:00-07:30 \u00a0\u00a0 Greiner <\/strong>Reggeli Fut\u00e1s<\/p>\n

         <\/p>\n

        CT1\u00a0\u00a0\u00a0\u00a0\u00a0 09:00-11:00\u00a0\u00a0\u00a0\u00a0 Novel aspects of cardiac electrophysiological remodeling \/Trends in translational research on age-related non-communicable diseases \u2013in
        \nco-organization with the Hungarian Center of Excellence for \u00a0Translational Medicine \u2013 T\u00f6lgyes Terem<\/strong><\/p>\n

        Eln\u00f6k:<\/u> Baczk\u00f3 Istv\u00e1n, Kiss Attila, Varga Zolt\u00e1n, Christoph Sensen<\/p>\n

        09:00<\/strong>\u00a0\u00a0 Attila Kiss<\/strong>1<\/sup>, Lujza Szab\u00f31<\/sup>, Janine Ebner2<\/sup>, Xaver K\u00f6nig2<\/sup>, Ouafa Hamza1<\/sup>, Dietmar Abraham3<\/sup>, Karlheinz Hilber1<\/sup>, Bruno Podesser1<\/sup><\/p>\n

        1<\/sup>Ludwig Boltzmann Institute for Cardiovascular Research at Center for Biomedical Research, Medical University of Vienna, Vienna 2<\/sup>Department of Neurophysiology and- pharmacology, Center for Physiology and Pharmacology, Medical University of Vienna 3<\/sup>Center for Anatomy and Cell Biology, Medical University of Vienna, Vienna<\/p>\n

        Cardiovascular phenotype of a rat model for Duchenne muscular dystrophy<\/em><\/p>\n

        09:15\u00a0\u00a0 <\/strong>Tibor Hornyik<\/strong>1,3,4<\/sup>, Alessandro Castiglione3,4,5<\/sup>, Eike M. W\u00fclfers6<\/sup>, Lucilla Giammarino4,5<\/sup>, Iask Edler7<\/sup>, Jessica J. Jowais8<\/sup>, Marina Rieder3,4,5<\/sup>, Stefanie Perez-Feliz3,6<\/sup>, Zsuzsanna B\u0151sze9<\/sup>, Andr\u00e1s Varr\u00f31,2<\/sup>, Michael Brunner3,10<\/sup>, Sara I. Liin7<\/sup>, Hans Peter Larsson8<\/sup>, Katja E. Odening3,4,5<\/sup> and Istv\u00e1n Baczk\u00f31<\/sup><\/p>\n

        1<\/sup>Department of Pharmacology and Pharmacotherapy, University of Szeged, Szeged 2<\/sup>ELKH-SZTE Research Group for Cardiovascular Pharmacology, E\u00f6tv\u00f6s Lor\u00e1nd Research Network, Szeged 3<\/sup>Department of Cardiology and Angiology I, University Heart Center Freiburg, Medical Faculty, University of Freiburg, Freiburg, Germany 4<\/sup>Department of Translational Cardiology\/Electrophysiology,Institute of Physiology, University of Bern, Bern, Switzerland 5<\/sup>Translational Cardiology, Department of Cardiology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland 6<\/sup>Institute of Experimental Cardiovascular Medicine, University Heart Center Freiburg\u2014Bad Krozingen, Medical Faculty, University of Freiburg, Freiburg, Germany 7<\/sup>Department of Biomedical and Clinical Sciences, Link\u00f6ping University, Link\u00f6ping, Sweden 8<\/sup>Department of Physiology and Biophysics, University of Miami, Miami, FL, USA 9<\/sup>Animal Biotechnology Department, NARIC Agricultural Biotechnology Institute, G\u00f6d\u00f6ll\u0151 10<\/sup>Department of Cardiology and Medical Intensive Care, St. Josefskrankenhaus, Freiburg, Germany
        \n<\/strong>Activation of the slow delayed rectifier potassium current normalizes QT interval in long QT type 2 transgenic rabbit models in a genotype-specific fashion<\/em><\/p>\n

        09:30\u00a0\u00a0 <\/strong>Horv\u00e1th Bal\u00e1zs<\/strong>1<\/sup>, H\u00e9zs\u0151 Tam\u00e1s1<\/sup>, \u00e1rp\u00e1dffy-Lovas Tam\u00e1s2<\/sup>, Fujii Erika1<\/sup>, Veress Roland3<\/sup>, Dienes Csaba1<\/sup>, Kov\u00e1cs Zsigmond1<\/sup>, Szentandr\u00e1ssy Norbert1<\/sup>, Vir\u00e1g L\u00e1szl\u00f32<\/sup>, Baczk\u00f3 Istv\u00e1n2<\/sup>, Varr\u00f3 Andr\u00e1s2<\/sup>, N\u00e1n\u00e1si P\u00e9ter P\u00e1l1<\/sup><\/p>\n

        1<\/sup>Debreceni Egyetem, \u00c1ltal\u00e1nos Orvostudom\u00e1nyi Kar, \u00c9lettani Int\u00e9zet, Debrecen 2<\/sup>Szegedi Tudom\u00e1nyegyetem, Farmakol\u00f3giai \u00e9s Farmakoter\u00e1piai Int\u00e9zet, Szeged 3<\/sup>Ohio State University, Department of Physiology and Cell biology<\/p>\n

        A k\u00e9s\u0151i n\u00e1trium\u00e1ram akci\u00f3s potenci\u00e1l alatti dinamik\u00e1ja tengerimalac, kutya, \u00e9s hum\u00e1n bal kamrai sz\u00edvizomsejtekben<\/em><\/p>\n

        09:45\u00a0\u00a0 <\/strong>G\u00e1sp\u00e1r R\u00f3bert<\/strong>1<\/sup>, Sz\u0171cs K\u00e1lm\u00e1n1<\/sup>, Vigh D\u00f3ra1<\/sup>, Grosz Gy\u00f6rgy2<\/sup>, S\u00fcle Mikl\u00f3s2<\/sup>, Prib\u00e9k Ildik\u00f33<\/sup>, And\u00f3 B\u00e1lint3<\/sup>, Datki Zsolt3<\/sup>, K\u00e1lm\u00e1n J\u00e1nos3<\/sup><\/p>\n

        1<\/sup>SZTE SZAOK Farmakol\u00f3giai \u00e9s Farmakoter\u00e1piai Int\u00e9zet, Szeged 2<\/sup>MSB-MET Kft, Balatonf\u00fcred 3<\/sup>SZTE SZAOK Pszichi\u00e1triai Klinika, Szeged<\/p>\n

        A simaizom elektromiogr\u00e1fia experiment\u00e1lis \u00e9s klinikai alkalmaz\u00e1si lehet\u0151s\u00e9gei<\/em><\/p>\n

        10:00\u00a0\u00a0 <\/strong>Christoph W. Sensen<\/strong><\/p>\n

        Hungarian Centre of Excellence for Molecular Medicine, Szeged
        \nEarly diagnostics of the onset of sepsis<\/em><\/p>\n

        10:15<\/strong>\u00a0\u00a0 Lea Danics1,2<\/sup>, Anna Abbas1,2<\/sup>, Bal\u00e1zs Kis1,2<\/sup>, Roger A. Barker3<\/sup>, Zolt\u00e1n L. Ver\u00e9b4<\/sup>, Johan Jakobsson5<\/sup>, Lajos Kem\u00e9ny4,6<\/sup>, Karolina Pircs<\/strong>1,2,5<\/sup><\/p>\n

        1<\/sup> HCEMM-SU, Neurobiology and Neurodegenerative Diseases Research Group, Budapest 2<\/sup>Institute of Translational Medicine, Semmelweis University, Budapest 3 <\/sup>Wellcome-MRC Cambridge Stem Cell Institute & John van Geest Centre for Brain Repair, Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK 4<\/sup> Department of Dermatology and Allergology, University of Szeged, Szeged 5 <\/sup>Laboratory of Molecular Neurogenetics, Department of Experimental Medical Science, Wallenberg Neuroscience Center and Lund Stem Cell CenterLund University, Lund, Sweden 6 <\/sup>HCEMM-USZ Skin Research Group, Szeged
        \nMind+: a new drug screening strategy for age-related cognitive disorders using induced neurons directly reprogrammed from patient\u2019s fibroblasts<\/em><\/p>\n

        10:30<\/strong>\u00a0\u00a0\u00a0 Csaba B\u00f6d\u00f6r<\/strong><\/p>\n

        HCEMM-SE HCEMM-SE Molecular Oncohematology Research Group, Semmelweis University, Budapest
        \nIdentification of novel biomarkers and targets for therapy in B-cell lymphomas<\/em><\/p>\n

        10:45\u00a0\u00a0 Round table discussion<\/strong><\/p>\n

         <\/p>\n

        09:00-11:00\u00a0\u00a0\u00a0\u00a0 Advancing EV-based therapeutics and diagnostics towards the market: challenges and achievements- B\u00fckk\u00f6s Terem
        \n<\/strong>Eln\u00f6k<\/u>: Buz\u00e1s Edit, Giricz Zolt\u00e1n, Varga Zolt\u00e1n<\/p>\n

        09:00<\/strong>\u00a0\u00a0 Silke<\/strong> Dorner <\/strong><\/p>\n

        Austrian Agency for Health and Food Safety, Vienna, Austria<\/p>\n

        Regulatory challenges for EV-based therapeutics<\/em><\/p>\n

        09:30\u00a0\u00a0 Tam\u00e1s <\/strong>Visnovitz<\/strong>1<\/sup>, Koncz Anna1<\/sup>, N\u00e9meth Krisztina1<\/sup>, Alm\u00e1si Anna1,2<\/sup>, Csomos Attila3<\/sup>, V. Vukman Krisztina1<\/sup>, Xabier Osteikoetxea1,5<\/sup>, Mucsi Zolt\u00e1n4<\/sup>, Buz\u00e1s Edit 1,5,6<\/sup><\/p>\n

        1<\/sup>Semmelweis Egyetem, \u00c1OK, Genetikai, Sejt- \u00e9s Immunbiol\u00f3giai Int\u00e9zet, Budapest 2<\/sup>P\u00e9csi Tudom\u00e1ny Egyetem, Egy\u00e9szs\u00e9gtudom\u00e1nyi Kar, KLK, P\u00e9cs 3<\/sup>E\u00f6tv\u00f6s Lor\u00e1nd Tudom\u00e1nyegyetem, TTK, Hevesy Gy\u00f6rgy Doktori Iskola, Budapest 4<\/sup>Miskolci Egyetem, Anyagtudom\u00e1nyi Kar, K\u00e9mia Int\u00e9zet, Miskolc 5<\/sup>HCEMM-SU Extracellular Vesicles Research Group, Budapest 6<\/sup>ELKH-SE Immun-Proteogenomikai Extracellul\u00e1ris Vezikula Kutat\u00f3csoport, Budapest<\/p>\n

        Development of lipid-based bioassays for standardization of EV preparations<\/em><\/p>\n

        10:00\u00a0\u00a0 <\/strong>Anik\u00f3 Ga\u00e1l<\/strong>1<\/sup>, Edwin van der Pol2,3,4<\/sup>, Rienk Nieuwland2,3<\/sup>, Zolt\u00e1n Varga1<\/sup><\/p>\n

        1<\/sup>Biological Nanochemistry Group, Research Centre for Natural Sciences, Budapest 2<\/sup>Department of Clinical Chemistry, Amsterdam UMC, University of Amsterdam location AMC, Amsterdam, the Netherlands 3 <\/sup>Vesicle Observation Center, Amsterdam UMC, University of Amsterdam location AMC, Amsterdam, the Netherlands 4 <\/sup>Department of Biomedical Engineering and Physics, Amsterdam UMC location AMC, University of Amsterdam, Amsterdam, the Netherlands
        \nManufacturing of hollow organosilicate reference particles for optical detection of EVs<\/em><\/p>\n

        10:30\u00a0\u00a0 <\/strong>\u00c9va P\u00e1llinger1<\/sup>,<\/sub> \u00c1rp\u00e1d Kov\u00e1cs<\/strong>2<\/sup>, Zolt\u00e1n Bogn\u00e1r3<\/sup>, Edit Buz\u00e1s1,4,5<\/sup>, J\u00falia Szekeres-Barth\u00f33<\/sup><\/p>\n

        1<\/sup>Dept. of Genteics, Cell- and Immunobiology, Semmelweis University, Budapest 2<\/sup>2nd Department of Paediatrics, Semmelweis University, Budapest 3<\/sup>Department of Medical Biology and Central Electron Microscope Laboratory, University of P\u00e9cs 4<\/sup>ELKH-SE Immune-Proteogenomics Extracellular Vesicle Research Group 5<\/sup>HCEMM-SU Extracellular Vesicle Research Group<\/p>\n

        A simple-rapid flow cytometry -based assay to identify a competent embryo prior to embryo transfer<\/em>\u00a0<\/em><\/p>\n

         <\/p>\n

        11:00\u00a0\u00a0 K\u00e1v\u00e9sz\u00fcnet<\/strong><\/p>\n

         <\/p>\n

        11:20-13:20\u00a0\u00a0\u00a0\u00a0 Transzl\u00e1ci\u00f3s \u00e9s klinikai farmakol\u00f3gia- T\u00f6lgyes Terem
        \n<\/strong>Eln\u00f6k:<\/u> Ferdinandy P\u00e9ter<\/p>\n

        11:20\u00a0\u00a0 <\/strong>Szentiv\u00e1nyi M\u00e1ty\u00e1s<\/strong><\/p>\n

        National Institute of Pharmacy and Nutrition, Budapest<\/p>\n

        Clinical trials in the light of the new regulations<\/em>\u00a0<\/em><\/strong><\/p>\n

        11:35<\/strong>\u00a0\u00a0 Ren\u00e1ta Papp<\/strong>1<\/sup>, J\u00e1nos Filakovszky2<\/sup> Attila Szab\u00f33<\/sup>, P\u00e9ter Ferdinandy1<\/sup>,<\/p>\n

        1<\/sup>Department of Pharmacology and Pharmacotherapy, Budapest 2<\/sup>Institute of Digital Health Sciences, Budapest 3<\/sup>Clinical Centre, Semmelweis University, Budapest<\/span><\/p>\n

        Facilitating industrial clinical trials at Semmelweis University<\/em><\/p>\n

        11:50\u00a0\u00a0 <\/strong>Kardon Tam\u00e1s<\/strong>, Schaff Zsuzsa<\/p>\n

        Medical Research Committee of the National Research Council, Budapest<\/p>\n

        How the ethical committee can contribute to advance innovations in clinical trials<\/em><\/p>\n

        12:05\u00a0\u00a0 <\/strong>B\u00e1lint Er\u0151ss<\/strong>1,2<\/sup><\/p>\n

        1<\/sup>Semmelweis Egyetem, V\u00e1rosmajori Sz\u00edv \u00e9s \u00c9rgy\u00f3gy\u00e1szati Klinika, Pankre\u00e1sz Betegs\u00e9gek R\u00e9szlege, Budapest 2<\/sup>Semmelweis Egyetem Transzl\u00e1ci\u00f3s Medicina K\u00f6zpont, Budapest<\/p>\n

        Translational medicine \u2013 innovations in teachning and research to advance investigator initiated clinical trials<\/em><\/p>\n

        12:20\u00a0\u00a0 <\/strong>Leszek Przemyslaw<\/strong><\/p>\n

        Department of Heart Failure and Transplantology, The Cardinal Stefan Wyszy\u0144ski National Institute of Cardiology, Warsaw, Poland<\/p>\n

        Human heart biobank \u2013 importance for translational research \u2013 methods and examples<\/em>\u00a0<\/em><\/strong><\/p>\n

        12:35\u00a0\u00a0 <\/strong>Sandor Kerpel-Fronius<\/strong><\/p>\n

        Department of Pharmacology and Pharmacotherapy, Semmelweis University, Budapest<\/p>\n

        Ethical and practical problems associated with translation medicine<\/em><\/p>\n

        12:50\u00a0\u00a0 <\/strong>Roundtable discussion<\/strong><\/p>\n

         <\/p>\n

        11:20-13:20\u00a0\u00a0\u00a0\u00a0 \u00daj, hat\u00e9kony gy\u00f3gyszerek kifejleszt\u00e9s\u00e9t megalapoz\u00f3 hazaieredm\u00e9nyek- B\u00fckk\u00f6s Terem
        \n<\/strong>Eln\u00f6k:<\/u> Bagdy Gy\u00f6rgy<\/p>\n

        11:20<\/strong>\u00a0\u00a0 Dr. Bagdy Gy\u00f6rgy<\/strong>1,3,4<\/sup>, Dr. Juh\u00e1sz Gabriella1,2,3,4<\/sup><\/p>\n

        1<\/sup>Gy\u00f3gyszerhat\u00e1stani Int\u00e9zet, Semmelweis Egyetem, Budapest 2<\/sup>SE-NAP 2 Genetikai Agyi K\u00e9palkot\u00f3 Migr\u00e9n Kutat\u00f3 Csoport, Nemzeti Agykutat\u00e1si Program, Semmelweis Egyetem, Budapest 3<\/sup>NAP-2-SE \u00daj Antidepressz\u00edv Gy\u00f3gyszerc\u00e9lpont Kutat\u00f3csoport, Semmelweis Egyetem, Budapest 4<\/sup>MTA-SE Neuropszichofarmakol\u00f3giai \u00e9s Neurok\u00e9miai Kutat\u00f3csoport, Semmelweis Egyetem, Budapest<\/p>\n

        Budapesti laborat\u00f3riumunk szerepe a CGRP hat\u00e1s\u00e1t g\u00e1tl\u00f3 migr\u00e9n ellenes szerek kifejleszt\u00e9s\u00e9ben \u00e9s a 2021-es brain prize d\u00edjban<\/em>
        \n<\/em><\/p>\n

        11:44<\/strong>\u00a0\u00a0 Koncz Szabolcs<\/strong>, Papp No\u00e9mi, Pothorszki D\u00f3ra, Bagdy Gy\u00f6rgy<\/p>\n

        Gy\u00f3gyszerhat\u00e1stani Int\u00e9zet, Gy\u00f3gyszer\u00e9sztudom\u00e1nyi Kar, Semmelweis Egyetem, Budapest<\/p>\n

        Gyorsan hat\u00f3 antidepressz\u00e1nsok qEEG hat\u00e1sai <\/em><\/p>\n

        12:08<\/strong>\u00a0\u00a0 Pothorszki D\u00f3ra<\/strong>1<\/sup>, Dr. Koncz Szabolcs1<\/sup>, Dr. Papp No\u00e9mi1<\/sup>, Dr. Bagdy Gy\u00f6rgy1,2,3<\/sup><\/p>\n

        1<\/sup>Gy\u00f3gyszerhat\u00e1stani Int\u00e9zet, Semmelweis Egyetem, Budapest 2<\/sup>NAP-2-SE \u00daj Antidepressz\u00edv Gy\u00f3gyszerc\u00e9lpont Kutat\u00f3csoport, Semmelweis Egyetem, Budapest 3<\/sup>MTA-SE Neuropszichofarmakol\u00f3giai \u00e9s Neurok\u00e9miai Kutat\u00f3csoport, Semmelweis Egyetem, Budapest<\/p>\n

        A tramadol hat\u00e1sai a REM alv\u00e1sra az akt\u00edv \u00e9s a passz\u00edv f\u00e1zisban<\/em><\/p>\n

        12:32<\/strong>\u00a0\u00a0 Papp No\u00e9mi<\/strong>, Koncz Szabolcs, Pothorszki D\u00f3ra, Bagdy Gy\u00f6rgy<\/p>\n

        Gy\u00f3gyszerhat\u00e1stani Int\u00e9zet, Gy\u00f3gyszer\u00e9sztudom\u00e1nyi Kar, Semmelweis Egyetem, Budapest<\/p>\n

        Gamma oszcill\u00e1ci\u00f3 – a ter\u00e1piarezisztencia lehets\u00e9ges prediktora pszichi\u00e1triai k\u00f3rk\u00e9pekben<\/em><\/p>\n

        12:56<\/strong>\u00a0\u00a0 Eszl\u00e1ri N\u00f3ra<\/strong>1,2<\/sup>, Bagyura Zsolt3<\/sup>, Millinghoffer Andr\u00e1s2,4<\/sup>, Nagy Tam\u00e1s4<\/sup>, Juh\u00e1sz\u00a0Gabriella1,5,6<\/sup>, Antal P\u00e9ter4<\/sup>, Merkely B\u00e9la3<\/sup>, Bagdy Gy\u00f6rgy1,2,5<\/sup><\/p>\n

        1<\/sup>Semmelweis Egyetem, Gy\u00f3gyszer\u00e9sztudom\u00e1nyi Kar, Gy\u00f3gyszerhat\u00e1stani Int\u00e9zet, Budapest 2<\/sup>NAP-2-SE \u00daj Antidepressz\u00edv Gy\u00f3gyszerc\u00e9lpont Kutat\u00f3csoport, Nemzeti Agykutat\u00e1si Program, Semmelweis Egyetem, Budapest 3<\/sup>Semmelweis Egyetem, \u00c1ltal\u00e1nos Orvostudom\u00e1nyi Kar, V\u00e1rosmajori Sz\u00edv- \u00e9s \u00c9rgy\u00f3gy\u00e1szati Klinika, Budapest 4<\/sup>Budapesti M\u0171szaki \u00e9s Gazdas\u00e1gtudom\u00e1nyi Egyetem, M\u00e9r\u00e9stechnika \u00e9s Inform\u00e1ci\u00f3s Rendszerek Tansz\u00e9k, Budapest 5<\/sup>MTA-SE Neuropszichofarmakol\u00f3giai \u00e9s Neurok\u00e9miai Kutat\u00f3csoport, Magyar Tudom\u00e1nyos Akad\u00e9mia, Semmelweis Egyetem, Budapest 6<\/sup>SE-NAP 2 Genetikai Agyi K\u00e9palkot\u00f3 Migr\u00e9n Kutat\u00f3 Csoport, Nemzeti Agykutat\u00e1si Program, Semmelweis Egyetem, Budapest<\/p>\n

        A catenin-alfa2 egy potenci\u00e1lis \u00faj gy\u00f3gyszerc\u00e9lpont pszichi\u00e1triai betegs\u00e9gekben<\/em><\/p>\n

        13:20-13:40\u00a0\u00a0\u00a0\u00a0 Poszter d\u00edj\u00e1tad\u00e1s, Ifj\u00fas\u00e1gi D\u00edj\u00e1tad\u00e1s, A Konferencia z\u00e1r\u00e1sa – T\u00f6lgyes Terem<\/strong>\u00a0<\/strong><\/p>\n

        13:20\u00a0\u00a0 Poszter D\u00edj\u00e1tad\u00e1s <\/strong><\/p>\n

        13:30\u00a0\u00a0 Ifj\u00fas\u00e1gi D\u00edj\u00e1tad\u00e1s<\/strong><\/p>\n

        Helyes Zsuzsanna\u00a0<\/strong><\/p>\n

        13:35\u00a0\u00a0 Z\u00e1rsz\u00f3<\/strong><\/p>\n

        Ferdinandy P\u00e9ter<\/p>\n

        13:40\u00a0\u00a0 <\/strong>Eb\u00e9d AVAR Hotel **** superior \u00c9tterem<\/strong><\/p>\n

         <\/p>\n

         <\/p>\n","protected":false},"excerpt":{"rendered":"

        A konferencia\u00a0 programja   j\u00fanius 7. (kedd) 11:00\u00a0\u00a0 Regisztr\u00e1ci\u00f3 12:00\u00a0\u00a0 Eb\u00e9d-AVAR Hotel **** superior \u00c9tterem 13:00-13:45\u00a0\u00a0\u00a0\u00a0 Konferencia megnyit\u00e1sa-T\u00f6lgyes terem 13:00 \u00a0Monostory Katalin: K\u00f6sz\u00f6nt\u0151 13:05 \u00a0Vizi E. Szilveszter: A Magyar K\u00eds\u00e9rletes \u00e9s Klinikai Farmakol\u00f3giai T\u00e1rsas\u00e1g hozz\u00e1j\u00e1rul\u00e1sa a magyar tudom\u00e1ny fejl\u0151d\u00e9s\u00e9hez az elm\u00falt 60 \u00e9vben 13:25\u00a0 Ferdinandy P\u00e9ter: Az MFT strat\u00e9giai szerepe a j\u00f6v\u0151ben a hazai preklinikai- Tov\u00e1bb … <\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_themeisle_gutenberg_block_has_review":false},"categories":[1],"tags":[],"_links":{"self":[{"href":"https:\/\/huphar.org\/huphar60\/wp-json\/wp\/v2\/posts\/650"}],"collection":[{"href":"https:\/\/huphar.org\/huphar60\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/huphar.org\/huphar60\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/huphar.org\/huphar60\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/huphar.org\/huphar60\/wp-json\/wp\/v2\/comments?post=650"}],"version-history":[{"count":76,"href":"https:\/\/huphar.org\/huphar60\/wp-json\/wp\/v2\/posts\/650\/revisions"}],"predecessor-version":[{"id":787,"href":"https:\/\/huphar.org\/huphar60\/wp-json\/wp\/v2\/posts\/650\/revisions\/787"}],"wp:attachment":[{"href":"https:\/\/huphar.org\/huphar60\/wp-json\/wp\/v2\/media?parent=650"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/huphar.org\/huphar60\/wp-json\/wp\/v2\/categories?post=650"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/huphar.org\/huphar60\/wp-json\/wp\/v2\/tags?post=650"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}